These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12960815)

  • 1. Quality assurance in immunohistochemistry.
    Rhodes A
    Am J Surg Pathol; 2003 Sep; 27(9):1284-5; author reply 1285-6. PubMed ID: 12960815
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality assurance in immunohistochemistry.
    Zardawi IM
    Am J Surg Pathol; 2003 Sep; 27(9):1285; author reply 1285-6. PubMed ID: 12974242
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance.
    Barnes DM; Millis RR; Beex LV; Thorpe SM; Leake RE
    Eur J Cancer; 1998 Oct; 34(11):1677-82. PubMed ID: 9893651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology].
    Balaton AL; Coindre JM; Collin F; Ettore F; Fiche M; Jacquemier J; Le Doussal V; Mandard AM; Mathieu MC; Migeon C; Simony-Lafontaine J; Treilleux I; Verriele V; Vilain MO; Zafrani B
    Ann Pathol; 1996; 16(2):144-8. PubMed ID: 8767687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry.
    Yaziji H; Taylor CR; Goldstein NS; Dabbs DJ; Hammond EH; Hewlett B; Floyd AD; Barry TS; Martin AW; Badve S; Baehner F; Cartun RW; Eisen RN; Swanson PE; Hewitt SM; Vyberg M; Hicks DG;
    Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):513-20. PubMed ID: 18931614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists.
    Rüdiger T; Höfler H; Kreipe HH; Nizze H; Pfeifer U; Stein H; Dallenbach FE; Fischer HP; Mengel M; von Wasielewski R; Müller-Hermelink HK
    Am J Surg Pathol; 2002 Jul; 26(7):873-82. PubMed ID: 12131154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories.
    Regitnig P; Reiner A; Dinges HP; Höfler G; Müller-Holzner E; Lax SF; Obrist P; Rudas M; Quehenberger F
    Virchows Arch; 2002 Oct; 441(4):328-34. PubMed ID: 12404057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Web-based training for quality improvement between a field immunohistochemistry laboratory in Nigeria and its United States-based partner institution.
    Oluwasola AO; Malaka D; Khramtsov AI; Ikpatt OF; Odetunde A; Adeyanju OO; Sveen WE; Falusi AG; Huo D; Olopade OI
    Ann Diagn Pathol; 2013 Dec; 17(6):526-30. PubMed ID: 24095629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A National Quality Assurance program for breast immunohistochemistry: an Italian perspective.
    Guadagno E; De Rosa G; Nappi O
    Pathologica; 2018 Sep; 110(2):83-91. PubMed ID: 30546143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Academic and nonacademic laboratories perform equally on CIQC immunohistochemistry proficiency testing.
    Chen ZW; Neufeld H; Copete MA; Garratt J; Gilks CB; Torlakovic EE
    Am J Clin Pathol; 2013 Jul; 140(1):55-60. PubMed ID: 23765534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC.
    Leake R; Barnes D; Pinder S; Ellis I; Anderson L; Anderson T; Adamson R; Rhodes T; Miller K; Walker R
    J Clin Pathol; 2000 Aug; 53(8):634-5. PubMed ID: 11002770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of controls in immunohistochemistry: how to validate an antibody, from research to diagnosis].
    Adle-Biassette H; Grassi J; Verney C; Walker F; Choudat L; Hénin D
    Ann Pathol; 2007 Feb; 27(1):16-26. PubMed ID: 17568355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry.
    Terry J; Torlakovic EE; Garratt J; Miller D; Köbel M; Cooper J; Bahzad S; Pilavdzic D; O'Malley F; O'Brien AE; SenGupta S; Alport E; Têtu B; Knight B; Pettigrew NM; Berendt R; Wolber R; Trotter MJ; Riddell RH; Gaboury L; Elms F; Magliocco A; Barnes P; Gown AM; Gilks CB
    Appl Immunohistochem Mol Morphol; 2009 Oct; 17(5):375-82. PubMed ID: 19363444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach.
    Dekker TJ; ter Borg S; Hooijer GK; Meijer SL; Wesseling J; Boers JE; Schuuring E; Bart J; van Gorp J; Bult P; Riemersma SA; van Deurzen CH; Sleddens HF; Mesker WE; Kroep JR; Smit VT; van de Vijver MJ
    Breast Cancer Res Treat; 2015 Jul; 152(2):247-52. PubMed ID: 26041687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian external quality assurance program for breast cancer biomarkers.
    Terry J; Torlakovic E; Trotter M; Garratt J; Barnes P; Gown A; Pettigrew N; Gilks CB
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):486. PubMed ID: 20502320
    [No Abstract]   [Full Text] [Related]  

  • 16. [A simplified way of applying positive controls in immunohistochemistry].
    Chen SP; Ding Y; Gao MQ
    Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):693-4. PubMed ID: 17374219
    [No Abstract]   [Full Text] [Related]  

  • 17. Fit-for-Purpose Immunohistochemical Biomarkers.
    Torlakovic EE
    Endocr Pathol; 2018 Jun; 29(2):199-205. PubMed ID: 29696583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fixation and processing on the sensitivity of oestrogen receptor assay by immunohistochemistry in breast carcinoma.
    Lee H; Douglas-Jones AG; Morgan JM; Jasani B
    J Clin Pathol; 2002 Mar; 55(3):236-8. PubMed ID: 11896082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer testing scandal shines spotlight on black box of clinical laboratory testing.
    Hede K
    J Natl Cancer Inst; 2008 Jun; 100(12):836-7, 844. PubMed ID: 18544732
    [No Abstract]   [Full Text] [Related]  

  • 20. [ICC and IHC: techniques and quality assurance. Lessons from the French external quality assessment trials in IHC].
    Bellocq JP; Michiels JF; Egele C; Chenard MP
    Ann Pathol; 2012 Nov; 32(5 Suppl):S94-5. PubMed ID: 23127954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.